Current Report Filing (8-k)
July 20 2020 - 7:00AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
July 20, 2020
Commission File No. 000-16929
Soligenix, Inc.
(Exact name of small business issuer as
specified in its charter)
DELAWARE
|
|
41-1505029
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
29 Emmons Drive,
Suite B-10
Princeton, NJ
|
|
08540
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(609) 538-8200
|
(Issuer’s telephone number, including area code)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section
12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common Stock, par value $.001 per share
|
|
SNGX
|
|
The Nasdaq Capital Market
|
Common Stock Purchase Warrants
|
|
SNGXW
|
|
The Nasdaq Capital Market
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
On July 20, 2020, Soligenix, Inc. (the
“Company”) distributed a letter (the “Letter”) to stockholders and other Company contacts and issued a
press release (the “Press Release”) containing a copy of the Letter. The Letter highlights important catalysts for
second half of 2020.
A copy of the Press Release is attached
hereto as Exhibit 99.1. The attached material will be posted on the Company’s website at www.soligenix.com.
Item 9.01. Financial Statements
and Exhibits.
(d) Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Soligenix, Inc.
|
|
|
July 20, 2020
|
By:
|
/s/ Christopher J. Schaber
|
|
|
Christopher J. Schaber, Ph.D.
President and Chief Executive Officer
(Principal Executive Officer)
|
2
Soligenix (NASDAQ:SNGX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Soligenix (NASDAQ:SNGX)
Historical Stock Chart
From Sep 2023 to Sep 2024